---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-138767"
form_type: "8-K"
ticker: "ENGN"
cik: "0001980845"
company_name: "enGene Therapeutics Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:35:31.750588+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# enGene enters $100M ATM equity sale agreement with Jefferies

## Summary
- Entered Open Market Sale Agreement with Jefferies for ATM offering of common shares up to $100M.
- Jefferies receives up to 3% commission; shares sold under prospectus supplement dated Dec 20, 2024.
- Offering not available in Canada and company not obligated to sell any shares.
- Agreement terminable by either party; proceeds for general corporate purposes not specified.

## SEC filing metadata
- accession: 0000950170-24-138767
- form_type: 8-K
- ticker: ENGN
- cik: 0001980845
- company_name: enGene Therapeutics Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1980845/000095017024138767/0000950170-24-138767-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1980845/000095017024138767/engn-20241220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-138767
- JSON: https://secwatch.observer/filing/0000950170-24-138767.json
- Plain text: https://secwatch.observer/filing/0000950170-24-138767.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.